These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 17150023

  • 1. BiovaxID: a personalized therapeutic cancer vaccine for non-Hodgkin's lymphoma.
    Lee ST, Jiang YF, Park KU, Woo AF, Neelapu SS.
    Expert Opin Biol Ther; 2007 Jan; 7(1):113-22. PubMed ID: 17150023
    [Abstract] [Full Text] [Related]

  • 2. Therapeutic lymphoma vaccines: importance of T-cell immunity.
    Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW.
    Expert Rev Vaccines; 2006 Jun; 5(3):381-94. PubMed ID: 16827622
    [Abstract] [Full Text] [Related]

  • 3. BiovaxID idiotype vaccination: active immunotherapy for follicular lymphoma.
    Flowers CR.
    Expert Rev Vaccines; 2007 Jun; 6(3):307-17. PubMed ID: 17542746
    [Abstract] [Full Text] [Related]

  • 4. Recombinant, tumour-derived idiotype vaccination for indolent B cell non-Hodgkin's lymphomas: a focus on FavId.
    Hurvitz SA, Timmerman JM.
    Expert Opin Biol Ther; 2005 Jun; 5(6):841-52. PubMed ID: 15952914
    [Abstract] [Full Text] [Related]

  • 5. Translational development of vaccination strategies in follicular NHL.
    Sakamaki I, Qin H, Kwak LW.
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
    [Abstract] [Full Text] [Related]

  • 6. Drug evaluation: FavId, a patient-specific idiotypic vaccine for non-Hodgkin's lymphoma.
    Reinis M.
    Curr Opin Mol Ther; 2007 Jun; 9(3):291-8. PubMed ID: 17608028
    [Abstract] [Full Text] [Related]

  • 7. Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma.
    Schuster SJ, Neelapu SS, Gause BL, Janik JE, Muggia FM, Gockerman JP, Winter JN, Flowers CR, Nikcevich DA, Sotomayor EM, McGaughey DS, Jaffe ES, Chong EA, Reynolds CW, Berry DA, Santos CF, Popa MA, McCord AM, Kwak LW.
    J Clin Oncol; 2011 Jul 10; 29(20):2787-94. PubMed ID: 21632504
    [Abstract] [Full Text] [Related]

  • 8. Phase II trial of idiotype vaccination in previously treated patients with indolent non-Hodgkin's lymphoma resulting in durable clinical responses.
    Redfern CH, Guthrie TH, Bessudo A, Densmore JJ, Holman PR, Janakiraman N, Leonard JP, Levy RL, Just RG, Smith MR, Rosenfelt FP, Wiernik PH, Carter WD, Gold DP, Melink TJ, Gutheil JC, Bender JF.
    J Clin Oncol; 2006 Jul 01; 24(19):3107-12. PubMed ID: 16754937
    [Abstract] [Full Text] [Related]

  • 9. Vaccine strategies in the treatment of low-grade non-Hodgkin lymphoma.
    Koumarianou A, Kountourakis P, Economopoulos T.
    J Steroid Biochem Mol Biol; 2008 Apr 01; 109(3-5):230-2. PubMed ID: 18406604
    [Abstract] [Full Text] [Related]

  • 10. Idiotype vaccines for non-Hodgkin's lymphoma induce polyclonal immune responses that cover mutated tumor idiotypes: comparison of different vaccine formulations.
    Caspar CB, Levy S, Levy R.
    Blood; 1997 Nov 01; 90(9):3699-706. PubMed ID: 9345055
    [Abstract] [Full Text] [Related]

  • 11. Translational development of active immunotherapy for hematologic malignancies.
    Kwak LW.
    Semin Oncol; 2003 Jun 01; 30(3 Suppl 8):17-22. PubMed ID: 12881808
    [Abstract] [Full Text] [Related]

  • 12. Vaccination with syngeneic, lymphoma-derived immunoglobulin idiotype combined with granulocyte/macrophage colony-stimulating factor primes mice for a protective T-cell response.
    Kwak LW, Young HA, Pennington RW, Weeks SD.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10972-7. PubMed ID: 8855293
    [Abstract] [Full Text] [Related]

  • 13. Tumor-specific recombinant idiotype immunisation after chemotherapy as initial treatment for follicular non-Hodgkin lymphoma.
    Timmerman JM, Vose JM, Czerwinski DK, Weng WK, Ingolia D, Mayo M, Denney DW, Levy R.
    Leuk Lymphoma; 2009 Jan 01; 50(1):37-46. PubMed ID: 19125383
    [Abstract] [Full Text] [Related]

  • 14. Genetic idiotypic and tumor cell-based vaccine strategies for indolent non Hodgkin's lymphoma.
    Ruffini PA, Di Nicola M, Carlo-Stella C, Siena S, Gianni AM.
    Curr Gene Ther; 2005 Oct 01; 5(5):511-21. PubMed ID: 16250891
    [Abstract] [Full Text] [Related]

  • 15. Prolonged idiotypic vaccination against follicular lymphoma.
    Inoges S, Lopez-Diaz de Cerio A, Zabalegui N, Soria E, Villanueva H, Panizo C, Rodriguez-Caballero A, Suarez L, Pastor F, Rodriguez-Calvillo M, Orfao A, Bendandi M.
    Leuk Lymphoma; 2009 Jan 01; 50(1):47-53. PubMed ID: 19152172
    [Abstract] [Full Text] [Related]

  • 16. Complete molecular remissions induced by patient-specific vaccination plus granulocyte-monocyte colony-stimulating factor against lymphoma.
    Bendandi M, Gocke CD, Kobrin CB, Benko FA, Sternas LA, Pennington R, Watson TM, Reynolds CW, Gause BL, Duffey PL, Jaffe ES, Creekmore SP, Longo DL, Kwak LW.
    Nat Med; 1999 Oct 01; 5(10):1171-7. PubMed ID: 10502821
    [Abstract] [Full Text] [Related]

  • 17. Current status of therapeutic vaccines for non-Hodgkin's lymphoma.
    Hurvitz SA, Timmerman JM.
    Curr Opin Oncol; 2005 Sep 01; 17(5):432-40. PubMed ID: 16093791
    [Abstract] [Full Text] [Related]

  • 18. Phase III randomized study of autologous lymphoma-derived idiotype specific vaccination plus GM-CSF in patients with follicular lymphoma in first complete remission.
    Clin Adv Hematol Oncol; 2003 Jan 01; 1(1):67. PubMed ID: 16227966
    [No Abstract] [Full Text] [Related]

  • 19. Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study.
    McCormick AA, Reddy S, Reinl SJ, Cameron TI, Czerwinkski DK, Vojdani F, Hanley KM, Garger SJ, White EL, Novak J, Barrett J, Holtz RB, Tusé D, Levy R.
    Proc Natl Acad Sci U S A; 2008 Jul 22; 105(29):10131-6. PubMed ID: 18645180
    [Abstract] [Full Text] [Related]

  • 20. Idiotype-pulsed dendritic cell vaccination for B-cell lymphoma: clinical and immune responses in 35 patients.
    Timmerman JM, Czerwinski DK, Davis TA, Hsu FJ, Benike C, Hao ZM, Taidi B, Rajapaksa R, Caspar CB, Okada CY, van Beckhoven A, Liles TM, Engleman EG, Levy R.
    Blood; 2002 Mar 01; 99(5):1517-26. PubMed ID: 11861263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.